The Discounted Cash Flow (DCF) valuation of Moderna Inc (MRNA) is (161.52) USD. With the latest stock price at 48.54 USD, the upside of Moderna Inc based on DCF is -432.8%.
Based on the latest price of 48.54 USD and our DCF valuation, Moderna Inc (MRNA) is a sell. selling MRNA stocks now will result in a potential gain of 432.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 9.2% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (311.49) - (110.85) | (161.52) |
| Upside | -741.7% - -328.4% | -432.8% |